Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria
Autor: | Alicja Kasperska-Zajac, Aleksandra Damasiewicz-Bodzek, R. Grzanka |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
lcsh:Immunologic diseases. Allergy
medicine.medical_specialty Allergy Soluble Fas ligand (sFasL) Soluble tumor necrosis factor receptor type 2 (sTNF-R2) Inflammation Soluble Fas (sFas) Fas ligand 03 medical and health sciences 0302 clinical medicine Mediator Internal medicine medicine Receptor business.industry Research General Medicine medicine.disease Chronic spontaneous urticaria Endocrinology 030228 respiratory system Apoptosis Tumor necrosis factor alpha (TNF-α) Tumor necrosis factor alpha Soluble tumor necrosis factor receptor type 1 (sTNF-R1) medicine.symptom Signal transduction business lcsh:RC581-607 030215 immunology |
Zdroj: | Allergy, Asthma & Clinical Immunology, Vol 15, Iss 1, Pp 1-9 (2019) Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology |
ISSN: | 1710-1492 |
DOI: | 10.1186/s13223-019-0332-7 |
Popis: | Background There is increasing evidence pointing to the important role of tumor necrosis factor-alpha (TNF-α), a key inflammatory and apoptotic mediator in urticarial inflammation. However, the role of the TNF-α system and Fas/Fas ligand (FasL) in the apoptosis-inducing pathways in chronic spontaneous urticaria (CSU), remain unclear. Aim To determine circulating concentrations of TNF-α, soluble TNF-α receptor type 1 and type 2 (sTNF-R1 and sTNF-R2, respectively) as well as soluble Fas (sFas) and FasL (sFasL) in CSU subjects. Methods Serum TNF-α, sTNF-R1, sTNF-R2, sFas, sFasL concentrations were measured using enzyme-linked immunosorbent assay in CSU subjects and in the healthy subjects. Results TNF-α concentrations were significantly higher in CSU subjects and moderate-to-severe CSU than in the controls, while there were no significant differences in TNF-α concentrations between subjects with mild CSU and the controls. sTNF-R1 and sTNF-R2 concentrations were significantly higher in all CSU and moderate-severe CSU subjects vs. the controls. Serum concentrations were also significantly higher in mild CSU vs. the controls, but not in moderate-severe CSU vs. mild CSU. No significant differences were observed in sFas and sFasL concentrations between CSU subjects and the healthy controls. Significant correlations were found between concentrations of TNF-α and its receptors, as well as sTNF-R1 and sTNF-R2, but not with the urticaria activity score (UAS). There was no relationship between TNF-α/sTNF-R1/sTNF-R2 and sFas/sFasL pathways in CSU. Conclusions CSU is associated with the activation of the TNF-α/receptors signaling pathway, marked by increased circulating concentrations of TNF-α, sTNF-R1 and sTNF-R2, which are related to each other in this disease. In contrast, the circulating sFas/FasL system is not up-regulated in CSU, and sFas/sFasL may not be a useful marker of the activity/severity of urticarial processes. Considering the lack of significant changes in sFas/sFasL (mainly reflecting systemic apoptosis) in CSU patients, it appears that elevated serum TNF-α concentrations are related to its pro-inflammatory function rather than an enhanced systemic apoptotic response in CSU. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |